The Lyme disease spirochete Borrelia burgdorferi induces inflammation and apoptosis in cells from dorsal root ganglia

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Ramesh, Geeta ^a   Santana Gould, Lenay ^c   Inglis, Fiona M ^b   England, John D ^c   Philipp, Mario T ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b Tulane University   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Borrelia burgdorferi; CCL2 MCP 1; Dexamethasone; Dorsal root ganglia; IL 6; IL 8; Lyme neuroborreliosis; Neuronal apoptosis; Schwann cells

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 6; INTERLEUKIN 8;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BORRELIA BURGDORFERI; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; GLIA CELL; HUMAN; HUMAN CELL; LYME DISEASE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PERIPHERAL NEUROPATHY; RHESUS MONKEY; SCHWANN CELL; SPINAL GANGLION;

EID: 84880184442     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-88     Document Type: Article

References (88)

1. Halperin JJ. Lyme disease and the peripheral nervous system. Muscle Nerve 2003, 28:133-143.
2. Halperin JJ. Nervous system Lyme disease. J R Coll Physicians Edinb 2010, 40:248-255.
3. Fallon BA, Levin ES, Schweitzer PJ, Hardesty D. Inflammation and central nervous system Lyme disease. Neurobiol Dis 2010, 37:534-541.
4. Elamin M, Monaghan T, Mulllins G, Ali E, Corbett-Feeney O, Connell S, Counihan TJ. The clinical spectrum of Lyme neuroborreliosis. Ir Med J 2010, 103:46-49.
5. Bremell D, Hagberg L. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy). BMC Infect Dis 2011, 11:215-220.
6. Lana-Peixoto MA. Multiple sclerosis and positive Lyme serology. Arq Neuropsiquiatr 1994, 52:566-571.
7. Brinar VV, Habek M. Rare infections mimicking MS. Clin Neurol Neurosurg 2010, 112:625-628.
8. Kohler J. Lyme borreliosis: a case of transverse myelitis with syrinx cavity. Neurology 1989, 39:1553-1554.
9. Benach JL. Borrelia burgdorferi in the central nervous system. JAMA 1992, 268:872.
10. Oksi J, Kalimo H, Marttila RJ, Marjamäki M, Sonninen P, Nikoskelainen J, Viljanen MK. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996, 119:2143-2154.
11. Duray PH, Steere AC. Clinical pathologic correlations of Lyme disease by stage. Ann N Y Acad Sci 1988, 539:65-79.
12. Blanc F, Ballonzoli Marcel C, De Martino S, Jaulhac B, De Seze J. Lyme optic neuritis. J Neurol Sci 2010, 295:117-119.
13. Durovska J, Bazovska S, Pancak J, Zaborska M, Derdakova M, Traubner P. Infection with B. burgdorferi s.l., and the CNS demyelinating disease. A case report. Neuro Endocrinol Lett 2011, 32:411-414.
14. Bigi S, Aebi C, Nauer C, Bigler S, Steinlin M. Acute transverse myelitis in Lyme neuroborreliosis. Infection 2010, 38:413-416.
15. Vallat JM, Hugon J, Lubeau M, Leboutet MJ, Dumas M, Desproges-Gotteron R. Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology 1987, 37:749-753.
16. Logigian EL. Peripheral nervous system Lyme borreliosis. Semin Neurol 1997, 17:25-30.
17. Meurs L, Labeye D, Declercq I, Piéret F, Gille M. Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients. Eur Neurol 2004, 52:186-188.
18. Koc F, Bozdemir H, Pekoz T, Aksu HS, Ozcan S, Kurdak H. Lyme disease presenting as subacute transverse myelitis. Acta Neurol Belg 2009, 109:326-329.
19. Roberts ED, Bohm RP, Cogswell FB, Lanners HN, Lowrie RC, Povinelli L, Piesman J, Philipp MT. Chronic Lyme disease in the rhesus monkey. Lab Invest 1995, 72:146-160.
20. Ramesh G, Borda JT, Gill A, Ribka EP, Morici LA, Mottram P, Martin DS, Jacobs MB, Didier PJ, Philipp MT. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J Neuroinflammation 2009, 6:23-38.
21. Jackson CL. Brefeldin A revealing fundamental principles governing membrane dynamics and protein transport. Subcell Biochem 2000, 34:233-272.
22. Ramesh G, Alvarez X, Borda JT, Aye PP, Lackner AA, Sestak K. Visualizing cytokine-secreting cells in situ in the rhesus macaque model of chronic gut inflammation. Clin Diag Lab Immunol. 2005, 12:192-197.
23. Ramesh G, Borda JT, Dufour J, Kaushal D, Ramamoorthy R, Lackner AA, Philipp MT. Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol 2008, 173:1415-1427.
24. Burkey TH, Hingtgen CM, Vasko MR. Isolation and culture of sensory neurons from the dorsal-root ganglia of embryonic or adult rats. Methods Mol Med 2004, 99:189-202.
25. Ramesh G, Benge S, Pahar B, Philipp MT. A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi. J Neuroinflammation 2012, 9:72.
26. Zhou Y, Ling EA, Dheen ST. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated microglia. J Neurochem 2007, 102:667-678.
27. Gonzalez-Martinez T, Perez-Pinera P, Diaz-Esnal B, Vega JA. S-100 proteins in the human peripheral nervous system. Microsc Res Tech 2003, 60:633-638.
28. Shen D, Zhang Q, Gao X, Gu X, Ding F. Age-related changes in myelin morphology, electrophysiological property and myelin-associated protein expression of mouse sciatic nerves. Neurosci Lett 2011, 502:162-167.
29. Sprinkle TJ. 2′,3′-cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. Crit Rev Neurobiol 1989, 4:235-301.
30. Vroemen M, Weidner N. Purification of Schwann cells by selection of p75 low affinity nerve growth factor receptor expressing cells from adult peripheral nerve. J Neurosci Methods 2003, 124:135-143.
31. Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol 2003, 163:1291-1300.
32. Suchanek G, Kristoferitsch W, Stanek G, Bernheimer H. Anti-myelin antibodies in cerebrospinal fluid and serum of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth and other neurological diseases. Zentralbl Bakteriol Mikrobiol Hyg A 1986, 263:160-168.
33. Baig S, Olsson T, Höjeberg B, Link H. Cells secreting antibodies to myelin basic protein in cerebrospinal fluid of patients with Lyme neuroborreliosis. Neurology 1991, 41:581-587.
34. Aberer E, Brunner C, Suchanek G, Klade H, Barbour A, Stanek G, Lassmann H. Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol 1989, 26:732-737.
35. Tauber SC, Ribes S, Ebert S, Heinz T, Fingerle V, Bunkowski S, Kugelstadt D, Spreer A, Jahn O, Eiffert H, Nau R. Long-term intrathecal infusion of outer surface protein C from Borrelia burgdorferi causes axonal damage. J Neurpathol Exp Neurol 2011, 70:748-757.
36. Duray PH. The surgical pathology of human Lyme disease. An enlarging picture. Am J Surg Pathol 1987, 11:47-60.
37. Martin R, Gran B, Zhao Y, Markovic-Plese S, Bielekova B, Marques A, Sung MH, Hemmer B, Simon R, McFarland HF, Pinilla C. Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease. J Autoimmun 2001, 16:187-192.
38. Roberts ED, Bohm RP, Lowrie RC, Habicht G, Katona L, Piesman J, Philipp MT. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 1998, 178:722-732.
39. England JD, Bohm RP, Roberts ED, Philipp MT. Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol 1997, 41:375-384.
40. Camponovo F, Meier C. Neuropathy of vasculitic origin in a case of Garin-Boujadoux-Bannwarth syndrome with positive borrelia antibody response. J Neurol 1986, 233:69-72.
41. Halperin J, Luft B, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis. Peripheral nervous system manifestations. Brain 1990, 113:1207-1221.
42. Halperin JJ. Neuroborreliosis. Am J Med 1995, 98:52S-56S-56S-59S.
43. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992, 263:C1-C16.
44. Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996, 19:331-338.
45. Rothwell NJ, Strijbos PJ. Cytokines in neurodegeneration and repair. Int J Dev Neurosci 1995, 13:179-185.
46. Raivich G, Jones LL, Werner A, Blüthmann H, Doetschmann T, Kreutzberg GW. Molecular signals for glial activation: pro-and anti-inflammatory cytokines in the injured brain. Acta Neurochir Suppl 1999, 73:21-30.
47. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 2005, 18:315-321.
48. Weller M, Stevens A, Sommer N, Wiethölter H, Dichgans J. Cerebrospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis. Arch Neurol 1991, 48:837-841.
49. Grusell M, Widhe M, Ekerfelt C. Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis. J Neuroimmunol 2002, 131:173-178.
50. Widhe M, Jarefors S, Ekerfelt C, Vrethem M, Bergstrom S, Forsberg P, Ernerudh J. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis 2004, 189:1881-1891.
51. Widhe M, Skogman BH, Jarefors S, Eknefelt M, Eneström G, Nordwall M, Ekerfelt C, Croner S, Bergström S, Forsberg P, Ernerudh J. Up-regulation of Borrelia-specifc IL-4 and IFN-gamma-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis. Int Immunol 2005, 17:1283-1291.
52. Rasley A, Anguita J, Marriott I. Borrelia burgdorferi induces inflammatory mediator production by murine microglia. J Neuroimmunol 2002, 130:22-31.
53. Ramesh G, Alvarez AL, Roberts ED, Dennis VA, Lasater BL, Alvarez X, Philipp MT. Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. Eur J Immunol 2003, 33:2539-2550.
54. Ramesh G, Philipp MT. Pathogenesis of Lyme neuroborreliosis: mitogen-activated protein kinases Erk 1, Erk 2 and p38 in the response of astrocytes to Borrelia burgdorferi lipoproteins. Neurosci Lett 2005, 384:112-116.
55. Bernardino AL, Myers TA, Alvarez X, Hasegawa A, Philipp MT. Toll-like receptors: insights into their possible role in the pathogenesis of Lyme neuroborreliosis. Infect Immun 2008, 76:4385-4395.
56. Myers TA, Kaushal D, Philipp MT. Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells. PLoS Pathog 2009, 5:e1000659.
57. Melli G, Hoke A. Dorsal root ganglia sensory neuronal cultures: a tool for drug discovery for peripheral neuropathies. Expert Opin Drug Discov 2009, 4:1035-1045.
58. Jeon SM, Sung JK, Cho HJ. Expression of monocyte chemoattractant protein-1 and its induction by tumor necrosis factor receptor 1 in sensory neurons in the ventral rhizotomy model of neuropathic pain. Neuroscience 2011, 190:354-366.
59. Svenningsen FA, Colman DR, Pedraza L. Satellite cells of dorsal root ganglia are multipotential glial precursors. Neuron Glia Biol 2004, 1:85-93.
60. Nascimento RS, Santago MF, Marques SA, Allodi S, Martinez AM. Diversity among satellite glial cells in dorsal root ganglia of the rat. Braz J Med Res 2008, 41:1011-1017.
61. Gunjigake KK, Goto T, Nakao K, Kobayashi S, Yamaguchi K. Activation of satellite glial cells in rat trigeminal ganglion after upper molar extraction. Acta Histochem Cytochem 2009, 42:143-149.
62. Vogel US, Thompson RJ. Molecular structure, localization, and possible functions of the myelin-associated enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase. J Neurochem 1988, 50:1667-1677.
63. Lind D, Franken S, Kappler J, Jankowski J, Schilling K. Characterization of the neuronal marker NeuN as a multiply phosphorylated antigen with discrete subcellular localization. J Neurosci Res 2005, 79:295-302.
64. Guillot X, Semerano L, Decker P, Falgarone G, Boissier MC. Pain and immunity. Joint Bone Spine 2012, 79:228-236.
65. Dotevall L, Eliasson T, Hagberg L, Mannheimer C. Pain as presenting symptom in Lyme neuroborreliosis. Eur J Pain 2003, 7:235-239.
66. Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 2010, 229:26-50.
67. Wang XM, Hamza M, Wu TX, Dionne RA. Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: correlation to clinical pain. Pain 2009, 142:275-283.
68. Boddeke EW. Involvement of chemokines in pain. Eur J Pharmacol 2001, 429:115-119.
69. Eliav E, Benoliel R, Herzberg U, Kalladka M, Tal M. The role of IL-6 and IL-1 beta in painful perineural inflammatory neuritis. Brain Behav Immun 2009, 23:474-484.
70. Thirumangalakudi L, Yin L, Rao HV, Grammas P. IL-8 induces expression of matrix metalloproteinases, cell cycle and pro-apoptotic proteins, and cell death in cultured neurons. J Alzheimers Dis 2007, 11:305-311.
71. Miller RJ, Jung H, Bhangoo SK, White FA. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 2009, 194:417-449.
72. White FA, Jung H, Miller RJ. Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci USA 2007, 104:20151-20158.
73. White FA, Feldman P, Miller RJ. Chemokine signaling and the management of neuropathic pain. Mol Interv 2009, 9:188-195.
74. Jung H, Toth PT, White FA, Miller RJ. Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J Neurochem 2008, 104:254-263.
75. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, Forrest MJ. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 2003, 100:7947-7952.
76. Murata Y, Rydevik B, Nannmark U, Larsson K, Takahashi K, Kato Y, Olmarker K. Local application of interleukin-6 to dorsal root ganglion induces tumor necrosis factor-α in the dorsal root ganglion and results in apoptosis of the dorsal root ganglion cells. Spine (Phila Pa 1976) 2011, 36:926-932.
77. Pachner AR, Amemiya K, Delaney E, O'Neill T, Hughes CA, Zhang WF. Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology 1997, 49:147-152.
78. Dantzer R, Capuron L, Irwin MR, Miller AH, Ollat H, Perry VH, Rousey S, Yirmiya R. Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology 2008, 33:18-29.
79. Gaudet AD, Popovich PG, Ramer MS. Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation 2011, 8:110.
80. Rutkowski JL, Teite GF, Lincoln PM, Boyer PJ, Tennekoon GI, Kunkel SL. Signals for proinflammatory cytokine secretion by human Schwann cells. J Neuroimmunol 1999, 101:47-60.
81. Mahad DJ, Ransohoff RM. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol 2003, 15:23-32.
82. Stadelmann C, Wegner C, Brück W. Inflammation, demyelination and degeneration-recent insights from MS pathology. Biochim Biophys Acta 1812, 2011:275-282.
83. Siebert H, Sachse A, Kuziel WA, Maeda N, Bruck W. The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol 2000, 110:177-185.
84. Berende A, Oosting M, Kullberg BJ, Netea MG, Joosten LA. Activation of innate host defense mechanisms by Borrelia. Eur Cytokine Netw 2010, 21:7-18.
85. Livengood JA, Gilmore RD. Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi. Microbes Infect 2006, 8:2832-2840.
86. Sterka D, Rati DM, Marriott I. Functional expression of NOD2, a novel pattern recognition receptor for bacterial motifs, in primary murine astrocytes. Glia 2006, 53:322-330.
87. Chauhan VS, Sterka DG, Gray DL, Bost KL, Marriott I. Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi. J Immunol 2008, 180:8241-8249.
88. Chauhan VS, Sterka DG, Furr SR, Young AB, Marriott I. NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens. Glia 2009, 57:414-423.